Home Patent Forecast® Sectors Log In   Sign Up   Free Trial   Support   Contact   Pricing  
How it works Patent Forecast® Sectors Pricing Insights
Menu
Enjoy your FREE PREVIEW which shows only 2020 data and 25 documents. For full access, try it free at any time.        

Cannabis: Compositions

Read More News and Insights

Zogenix, GW Pharma Discovering Epilepsy Treatments

Cannabis: Compositions Patent Forecast®

April 16, 2020

Zogenix is searching for and developing treatments for rare diseases such as those that cause different forms of epilepsy. Just this week, Zogenix received a patent (US Pat. No. 10,603,290) for a treatment for seizures which uses fenfluramine in combination with cannabidiol to counter a metabolism pathway that creates norfenfluramine having undesired side effects. Cannabidiol has been combined with other drugs, such as botox, to downplay some of the side effects of the primary drug.

Zogenix is not alone in the cannabis for epilepsy space. In fact, as you may have already guessed, GW Pharmaceuticals was also listed this week for a grant for patent 10,603,288. Patent ‘288 claims a CBD composition, also in the presence of another epilepsy treating drug, for "treatment-resistant epilepsy".

GW Pharmaceuticals is the leading patent assignee in the cannabis sector. Take a custom look at the cannabis sector IP landscape at MagicNumberIP.com with a subscription.  

Cbd Öl, Cbd Oil, Hemp Oil, Oil, Cbd, Superfood, Hanf

Relevant Patent Documents

Patent US10603290  

Patent US10603288  


Read more like this in News This Week!   or   Share this link with your connections!



301